大禹生物
(920970)
| 流通市值：4.73亿 | | | 总市值：7.48亿 |
| 流通股本：7007.13万 | | | 总股本：1.11亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 71,914,063.08 | 33,740,362.7 | 167,480,613.05 | 92,453,169.97 |
| 营业总成本 | 84,319,961.11 | 38,871,433.38 | 199,734,100.78 | 105,747,869.62 |
| 其他经营收益 | | | | |
| 营业利润 | -26,549,863.14 | -17,416,890.13 | -29,702,791.94 | -10,618,282.94 |
| 利润总额 | -26,549,609.3 | -17,416,636.89 | -29,823,809.91 | -10,715,018.11 |
| 净利润 | -26,549,609.3 | -17,416,636.89 | -29,853,181.08 | -10,716,270.61 |
| 每股收益 | | | | |
| 其他综合收益 | -6,880 | - | - | - |
| 综合收益总额 | -26,556,489.3 | -17,416,636.89 | -29,853,181.08 | -10,716,270.61 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 103,672,941.95 | 92,911,547.35 | 89,898,484.96 | 114,063,452.38 |
| 非流动资产: | | | | |
| 非流动资产合计 | 358,424,895 | 354,339,134.89 | 345,913,491.8 | 341,494,749.83 |
| 资产总计 | 462,097,836.95 | 447,250,682.24 | 435,811,976.76 | 455,558,202.21 |
| 流动负债: | | | | |
| 流动负债合计 | 159,702,908.66 | 138,797,758.84 | 115,265,805.18 | 115,023,841.57 |
| 非流动负债: | | | | |
| 非流动负债合计 | 65,438,786.46 | 62,356,929.16 | 57,033,540.45 | 57,884,819.04 |
| 负债合计 | 225,141,695.12 | 201,154,688 | 172,299,345.63 | 172,908,660.61 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 236,956,141.83 | 246,095,994.24 | 263,512,631.13 | 282,649,541.6 |
| 股东权益合计 | 236,956,141.83 | 246,095,994.24 | 263,512,631.13 | 282,649,541.6 |
| 负债和股东权益合计 | 462,097,836.95 | 447,250,682.24 | 435,811,976.76 | 455,558,202.21 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 82,563,300.05 | 35,344,932.86 | 198,208,247.83 | 117,141,457.68 |
| 经营活动现金流出小计 | 105,380,592.15 | 53,963,038.84 | 188,026,883.49 | 130,813,808.68 |
| 经营活动产生的现金流量净额 | -22,817,292.1 | -18,618,105.98 | 10,181,364.34 | -13,672,351 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | - | - | - | 268,534.82 |
| 投资活动现金流出小计 | 30,150,679.2 | 17,328,927.71 | 43,035,524.75 | 29,475,775.47 |
| 投资活动产生的现金流量净额 | -30,150,679.2 | -17,328,927.71 | -43,035,524.75 | -29,207,240.65 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 171,400,000 | 50,400,000 | 107,900,000 | 92,900,000 |
| 筹资活动现金流出小计 | 131,944,763.75 | 15,715,160.41 | 70,321,379.27 | 53,594,913.77 |
| 筹资活动产生的现金流量净额 | 39,455,236.25 | 34,684,839.59 | 37,578,620.73 | 39,305,086.23 |
| 汇率变动对现金及现金等价物的影响 | -19,261.26 | -5,570.36 | -4,869.48 | - |
| 现金及现金等价物净增加额 | -13,531,996.31 | -1,267,764.46 | 4,719,590.84 | -3,574,505.42 |
| 期末现金及现金等价物余额 | 16,862,428.27 | 29,126,660.12 | 30,394,424.58 | 22,100,328.32 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -13,531,996.31 | - | 4,719,590.84 | - |